Wallace Owen B, Richardson Timothy I, Dodge Jeffrey A
Lilly Research Laboratories, Indianapolis, IN 46285, USA.
Curr Top Med Chem. 2003;3(14):1663-82. doi: 10.2174/1568026033451727.
The estrogen receptor is a regulator of a wide range of physiological functions, including the female reproductive system, in addition to bone, cardiovascular and CNS function. ER ligands have been approved for the treatment of menopausal symptoms, breast cancer and osteoporosis, however the search continues for new modulators of ER function with improved properties. Progress in medicinal chemistry programs has resulted in the identification of structurally diverse molecules with unique biological properties. Recent advances in the design and synthesis of these non-steroidal and steroidal estrogen receptor ligands is reviewed. The relationship between the structural features of the ligand and receptor function is also discussed.
雌激素受体是多种生理功能的调节因子,除了骨骼、心血管和中枢神经系统功能外,还包括女性生殖系统。雌激素受体配体已被批准用于治疗更年期症状、乳腺癌和骨质疏松症,然而,人们仍在继续寻找具有更好特性的雌激素受体功能新调节剂。药物化学项目的进展已导致鉴定出具有独特生物学特性的结构多样的分子。本文综述了这些非甾体和甾体雌激素受体配体在设计和合成方面的最新进展。还讨论了配体的结构特征与受体功能之间的关系。